Leaflet CONCERTA 18mg prolonged-release film-coated tablets

Product code:
W43107001
Quantity:
28
Indicated for:
attention deficit hyperactivity disorder (ADHD)
Route of administration:
oral
Substance:
methylphenidate (psychostimulant)
ATC
N06BA04 — Nervous system | Psychostimulants, agents used for adhd and nootropics | Centrally acting sympathomimetics

Precautions:

Driving impairment

Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Dependence / abuse

Dependence / abuse

This medicine may cause dependence or be misused.

Seizure risk

Seizure risk

This medicine may increase the risk of seizures.

Methylphenidate is a medication primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It works by increasing dopamine and norepinephrine levels in the brain, which helps improve focus and reduce impulsivity.

The medication is available in immediate-release or extended-release tablet forms, and the dosage is adjusted based on the individual needs of the patient. Treatment with methylphenidate should be monitored by a doctor, as it may have side effects such as insomnia, loss of appetite, headaches, or increased blood pressure.

Methylphenidate is contraindicated in individuals with certain conditions, such as glaucoma, severe anxiety disorders, or a history of substance abuse. It is also important for patients to inform their doctor about any other medications they are taking to avoid drug interactions.

This medication should be used with caution in children, adolescents, and adults, and pregnant or breastfeeding women should consult their doctor before starting treatment.

General data about CONCERTA 18mg

Substance:
methylphenidate
Date of latest medicines list:
01-10-2014
Product code:
W43107001
Concentration:
18mg
Pharmaceutical form:
prolonged-release film-coated tablets
Quantity:
28
Product type:
Original
Prescription status:
TAB2 — Medicines dispensed with a special medical prescription for narcotic substances, yellow in color.

Marketing authorisation

Manufacturer:
JANSSEN PHARMACEUTICA N.V. - BELGIA
Holder:
JANSSEN PHARMACEUTICA N.V. - BELGIA
Number:
5339/2013/01
Shelf life:
3 years

Concentrations available for methylphenidate

  • 10mg
  • 18mg
  • 20mg
  • 27mg
  • 30mg
  • 36mg
  • 40mg
  • 54mg
  • 5mg